title: Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma.
authors.affiliation: Department of Hematology, Ospedali Riuniti di Ancona , Ancona , Italy.
authors.forename: Ilaria
authors.initials: I
authors.lastname: Scortechini
authors.forename: Mauro
authors.initials: M
authors.lastname: Montanari
authors.forename: Giorgia
authors.initials: G
authors.lastname: Mancini
authors.forename: Elena
authors.initials: E
authors.lastname: Inglese
authors.forename: Monica
authors.initials: M
authors.lastname: Calandrelli
authors.forename: Martina
authors.initials: M
authors.lastname: Chiarucci
authors.forename: Massimo
authors.initials: M
authors.lastname: Offidani
authors.forename: Debora
authors.initials: D
authors.lastname: Capelli
authors.forename: Guido
authors.initials: G
authors.lastname: Gini
authors.forename: Antonella
authors.initials: A
authors.lastname: Poloni
authors.forename: Stefania
authors.initials: S
authors.lastname: Mancini
authors.forename: Gianmario
authors.initials: G
authors.lastname: Raggetti
authors.forename: Pietro
authors.initials: P
authors.lastname: Leoni
authors.forename: Attilio
authors.initials: A
authors.lastname: Olivieri
mesh_terms: D004999:Amifostine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002330:Carmustine / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D008558:Melphalan / Q000008:administration & dosage; D010045:Outpatients; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D003561:Cytarabine; D005047:Etoposide; D004999:Amifostine; D008558:Melphalan; D002330:Carmustine